Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial
Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV/HIV co-infected individuals
Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell
Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C
Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats
Fas/FasL system, IL-1β expression and apoptosis in chronic HBV and HCV liver disease
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C
Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden – a low endemic country
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study